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Introduction: Schizophrenia, a complex psychotic disorder, is characterized by positive
symptoms, like delusions, hallucinations, and paranoia. Few studies have studied the
characteristics of patients who are “treatment resistant,” who do not respond to a broad range
of antipsychotics. Clozapine is an antipsychotic medication used to treat patients diagnosed
with schizophrenia who generally do not respond to other treatments. The relationship
between treatment-resistant schizophrenia, clozapine, and brain structure and function
warrants more study.
Purpose: There have been few research studies conducted in regards to the effects of clozapine
on the brain. Previous literature has suggested that clozapine decreases the function of the
basal ganglia. The investigators of this study are researching whether there are differences in
brain structure and function of schizophrenia patients that respond to clozapine compared to
those who do not respond.
Method: Our aim is to recruit about 40 patients who are stable on clozapine through the Grady
Behavioral Health Unit (GBHU). In order to conduct this study, participants attend two separate
visits with the researchers. The first visit is conducted at GBHU where the patients are
interviewed about demographics, general functioning, cognitive insight, and symptom severity
within a week of the conducted interview. The participant’s second visit is conducted at the
Center for Advanced Brain Imaging (CABI). Patients are administered cognitive tests that
measure components such as working memory, imagination, verbal fluency, and processing
speed. After the tests are completed, the patients undergo structural and functional magnetic
resonance imaging scans.
Results: This study is currently in progress. The hypothesized MRI results of the research study
are that Schizophrenia patients that show more severe symptoms will show aberrant activity in
brain functions while on clozapine.
Conclusion: This study will be one of few investigating differences among participants who
respond to clozapine and those who do not. We hope this research will further research studies
on the psychosis continuum.
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